Predicine to Introduce PredicineALERT™ MRD Assay and Present Two ctDNA Studies in Genitourinary Cancers at AUA 2023 Annual Meeting
28 avr. 2023 17h42 HE
|
Predicine
HAYWARD, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- Predicine, a global molecular insights company, announced today that it will present two studies and introduce PredicineALERT™ Minimal Residual...
Liquid Biopsy Market Size Worth USD 13.81 Billion by 2030 at 20.20% CAGR – Report by Market Research Future (MRFR)
09 mars 2023 12h15 HE
|
Market Research Future
New York, USA, March 09, 2023 (GLOBE NEWSWIRE) -- Liquid Biopsy Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Liquid Biopsy Market Information by...
Circulating Tumor Cells Global Market Report 2023: Widespread Adoption of CTC-Based Liquid Biopsy Boosts Growth
08 mars 2023 06h03 HE
|
Research and Markets
Dublin, March 08, 2023 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cells Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
United States Biopsy Market Report 2023: Sector to Reach $21.4 Billion by 2028 at a CAGR of 4.5%
03 mars 2023 09h13 HE
|
Research and Markets
Dublin, March 03, 2023 (GLOBE NEWSWIRE) -- The "United States Biopsy Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been...
World Liquid Biopsy Market Report 2023-2027: Market Share Assessments, Competitive Research, and Due Diligence for M&As
03 mars 2023 06h18 HE
|
Research and Markets
Dublin, March 03, 2023 (GLOBE NEWSWIRE) -- The "The World Market for Liquid Biopsy, 2023" report has been added to ResearchAndMarkets.com's offering. The World Liquid Biopsy Market, 2023,...
Predicine to Present Four Studies at 2023 ASCO Genitourinary (GU) Symposium Highlighting the Technical and Clinical Utility of Predicine’s Liquid Biopsy Based Assays
16 févr. 2023 16h05 HE
|
Predicine
HAYWARD, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Predicine, a global molecular insights company, is committed to advancing genitourinary (GU) cancer detection and treatment decisions through its...
Europe Biomarker Technologies Market Research Report 2022: Focus on Immunoassay, DDPCR, Next Generation Sequencing (NGS), Mass Spectrometry, DHPLC - Trends, Forecasts & Opportunities to 2028
09 févr. 2023 11h58 HE
|
Research and Markets
Dublin, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The "Europe Biomarker Technologies Market, By Test Type, By Technology (Immunoassay, DDPCR, Next Generation Sequencing (NGS), Mass Spectrometry, DHPLC,...
The Worldwide Circulating Tumor Cell (CTC) Diagnostics Industry is Projected to Reach $21.3 Billion by 2030: Increasing Research Reveal Further Complexities to CTC Composition and Behavior
09 févr. 2023 10h28 HE
|
Research and Markets
Dublin, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cell (CTC) Diagnostics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...
Global Liquid Biopsy Markets Report 2023: Cancer, Usage, Biomarker, Place, & Products Analysis with Price and Volume Outlook to 2027
08 févr. 2023 09h18 HE
|
Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and...
Global Liquid Biopsy Market Report 2022-2028: Competitive Developments, Strategies, Mergers, and Acquisitions, and New Biomarker Developments
02 févr. 2023 04h58 HE
|
Research and Markets
Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market - Analysis by Biomarker Type (CTCs, ctDNA, EVs, Others), Product (Assay Kits, Instruments and Devices, Services), By...